Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must have severe kidney disease~* Subjects who are matched to the kidney disease patients in terms of weight, age, and sex must have normal kidneys~* All women must be post-menopausal (no longer menstruating) or surgically sterile~Exclusion Criteria:~* Patients requiring dialysis~* History of allergy to aspirin or clopidogrel~* Have increased bleeding risk (for instance uncontrolled high blood pressure or a recent major injury)~* Recent history of fainting or light-headedness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- AZD6140 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).